JP2024503623A5 - - Google Patents
Info
- Publication number
- JP2024503623A5 JP2024503623A5 JP2023541041A JP2023541041A JP2024503623A5 JP 2024503623 A5 JP2024503623 A5 JP 2024503623A5 JP 2023541041 A JP2023541041 A JP 2023541041A JP 2023541041 A JP2023541041 A JP 2023541041A JP 2024503623 A5 JP2024503623 A5 JP 2024503623A5
- Authority
- JP
- Japan
- Prior art keywords
- lnp
- item
- lipid
- formula
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163134376P | 2021-01-06 | 2021-01-06 | |
| US63/134,376 | 2021-01-06 | ||
| US202163147959P | 2021-02-10 | 2021-02-10 | |
| US63/147,959 | 2021-02-10 | ||
| US202163181663P | 2021-04-29 | 2021-04-29 | |
| US202163181899P | 2021-04-29 | 2021-04-29 | |
| US202163181917P | 2021-04-29 | 2021-04-29 | |
| US63/181,917 | 2021-04-29 | ||
| US63/181,899 | 2021-04-29 | ||
| US63/181,663 | 2021-04-29 | ||
| PCT/US2022/011450 WO2022150485A1 (en) | 2021-01-06 | 2022-01-06 | Encapsulated rna polynucleotides and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503623A JP2024503623A (ja) | 2024-01-26 |
| JP2024503623A5 true JP2024503623A5 (https=) | 2025-02-03 |
Family
ID=82357635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541041A Pending JP2024503623A (ja) | 2021-01-06 | 2022-01-06 | カプセル化ｒｎａポリヌクレオチド及び使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240115636A1 (https=) |
| EP (1) | EP4274591A4 (https=) |
| JP (1) | JP2024503623A (https=) |
| KR (1) | KR20230143141A (https=) |
| AU (1) | AU2022206676A1 (https=) |
| CA (1) | CA3204244A1 (https=) |
| WO (1) | WO2022150485A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024542188A (ja) * | 2021-11-16 | 2024-11-13 | セイル バイオメディシンズ インコーポレイテッド | 新規イオン化可能な脂質および脂質ナノ粒子ならびにそれらを使用する方法 |
| WO2023223183A1 (en) * | 2022-05-16 | 2023-11-23 | Crispr Therapeutics Ag | Picornaviral vectors for gene editing |
| WO2024031078A2 (en) * | 2022-08-05 | 2024-02-08 | Elevatebio Technologies, Inc. | Chimeric oncolytic viruses with tropism for poliovirus receptor |
| KR20250126155A (ko) | 2022-11-04 | 2025-08-22 | 라이프 에디트 테라퓨틱스, 인크. | 내부 삽입 부위를 갖는 진화된 아데닌 데아미나제 및 rna-가이드 뉴클레아제 융합 단백질 및 사용 방법 |
| CN120826390A (zh) | 2023-01-31 | 2025-10-21 | 安斯泰来制药株式会社 | 具有环状胺的氨甲酰基脂质或脲脂质、含有其的脂质纳米粒子和药物组合物 |
| WO2024178397A2 (en) | 2023-02-24 | 2024-08-29 | Elevatebio Technologies, Inc. | Modified immune effector cells and methods of use |
| WO2024226832A1 (en) * | 2023-04-25 | 2024-10-31 | Orgenesis Inc. | Ribonucleases for treating viral infections |
| WO2025022367A2 (en) | 2023-07-27 | 2025-01-30 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
| WO2025083619A1 (en) | 2023-10-18 | 2025-04-24 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and acive fragments and variants thereof and methods of use |
| WO2025174908A1 (en) | 2024-02-12 | 2025-08-21 | Life Edit Therapeutics, Inc. | Novel rna-guided nucleases and proteins for polymerase editing |
| WO2026006491A1 (en) * | 2024-06-25 | 2026-01-02 | Cornell University | Senecavirus a (sva) vaccine compositions and methods thereof |
| WO2026003754A1 (en) | 2024-06-25 | 2026-01-02 | Life Edit Therapeutics, Inc. | Novel reverse transcriptases and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1843773A4 (en) * | 2005-01-17 | 2008-07-30 | Viralytics Ltd | METHOD AND COMPOSITION FOR TREATING NEOPLASIA |
| PL3386484T3 (pl) * | 2015-12-10 | 2022-07-25 | Modernatx, Inc. | Kompozycje i sposoby dostarczania środków terapeutycznych |
| KR20200036873A (ko) * | 2017-07-14 | 2020-04-07 | 온코루스, 인크. | 캡슐화된 폴리뉴클레오티드 및 사용 방법 |
| EP3675817A1 (en) * | 2017-08-31 | 2020-07-08 | Modernatx, Inc. | Methods of making lipid nanoparticles |
| US11679159B2 (en) * | 2018-04-29 | 2023-06-20 | Precision NanoSystems ULC | Compositions for transfecting resistant cell types |
| JP2022516318A (ja) * | 2019-01-04 | 2022-02-25 | オンコラス， インコーポレイテッド | カプセル化ポリヌクレオチド及び使用方法 |
| KR102732019B1 (ko) * | 2019-04-15 | 2024-11-20 | 글로벌 라이프 사이언시즈 솔루션즈 캐나다 유엘씨 | T 세포 유전자 발현의 비바이러스 변형 |
-
2022
- 2022-01-06 WO PCT/US2022/011450 patent/WO2022150485A1/en not_active Ceased
- 2022-01-06 AU AU2022206676A patent/AU2022206676A1/en active Pending
- 2022-01-06 JP JP2023541041A patent/JP2024503623A/ja active Pending
- 2022-01-06 EP EP22737107.7A patent/EP4274591A4/en not_active Withdrawn
- 2022-01-06 KR KR1020237026655A patent/KR20230143141A/ko active Pending
- 2022-01-06 US US18/260,375 patent/US20240115636A1/en active Pending
- 2022-01-06 CA CA3204244A patent/CA3204244A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024503623A5 (https=) | ||
| JP2022516318A5 (https=) | ||
| ES2256265T3 (es) | Vectores de parvovirus duplicados. | |
| JP2025063030A5 (https=) | ||
| JP2024508047A5 (https=) | ||
| JP2023528300A5 (https=) | ||
| JP2024531486A (ja) | 環状ｒｎａを調製するための構築物及び方法 | |
| JP2024503623A (ja) | カプセル化ｒｎａポリヌクレオチド及び使用方法 | |
| TW202425953A (zh) | 脂質奈米顆粒 (lnp) 綴合物的製備 | |
| CN108271387A (zh) | 乙型肝炎病毒感染的RNAi疗法 | |
| Cai et al. | Synthetic circRNA therapeutics: innovations, strategies, and future horizons | |
| Son et al. | Development of mRNA vaccines/therapeutics and their delivery system | |
| CN101307328A (zh) | 一种ck19重组腺相关病毒载体及其构建方法与应用 | |
| JP2018504896A5 (https=) | ||
| Kairuz et al. | Advancing mRNA technologies for therapies and vaccines: An African context | |
| JP2022507269A5 (https=) | ||
| CN116348148A (zh) | 显示出增强的药代动力学的工程化胞外囊泡 | |
| CA3143627A1 (en) | Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines | |
| JP2022058697A (ja) | インビボでの核酸発現のためのシステム及び方法 | |
| WO2024131403A1 (zh) | 基于核酸适体的脾脏及其亚细胞的mRNA靶向递送系统 | |
| CN105073141A (zh) | 用于将基因递送到细胞的功能化dna树状聚合物 | |
| KR102948789B1 (ko) | 항원 제시 세포를 표적으로 하는 지질 조성물 및 이의 용도 | |
| Qu et al. | Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons | |
| CN119654141A (zh) | 脂质纳米颗粒的组合物 | |
| Wang et al. | Targeted gene delivery systems for T-cell engineering |